Eli Lilly drug tirzepatide, marketed as Zepbound for weight management, has results from two Phase 3 studies showing reductions in the breathing problems caused by obstructive sleep apnea. Lilly is now preparing regulatory submissions to add this indication to the drug’s label.
When it comes to monitoring sleep, we need to stop talking about wearables and trackers, and talk about care model platforms.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A London company has developed a device, and a companion app, that can exercise the tongue and track progress so that snoring and mild-to-moderate sleep apnea symptoms abate at night.
No. "It's a logical double down on connected care," CEO Mick Farrell said - as ResMed plans to streamline the home medical equipment supply chain.
First TEDMED and now ... talk radio in the Canadian prairie? Dr. Zubin Damania, better known as ZDogg MD, for some reason called into a radio show on CKOM-AM in Saskatoon, Saskatchewan, last week to talk about his musical parodies of the rigors of the American healthcare industry.
The build up of fat in the liver and sleep apnea appear now to be closely related and primarily affect a particular demographic of obese people. In a study published last year in the journal Chest, researchers looked at 226 obese middle-aged men and women who were referred to a clinic because they were suspected of […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Most devices that treat sleep apnea are in the form of high-tech, oxygenated face masks – but a Minnesota startup is taking a different approach, building an implantable device that treats the common breathing disorder. Respicardia has raised $25 million, with about $20 million of that coming from the Milan-based Sorin Group. The Italian cardiac devicemaker which […]
Just a couple of weeks after securing U.S. Food and Drug Administration approval for its implant to treat obstructive sleep apnea, Inspire Medical Systems added three new investors in a Series E round raising $40 million. OrbiMed led the financing round and its private equity partner, Chau Q. Khuong, will sit on the board. Johnson […]
Penn Medicine is planning to expand its Center for Sleep and Circadian Neurobiology with the opening of a center in Mumbai, India in a joint venture with the Mahatma Gandhi Mission Institute of Health Sciences, MedCity News has learned. The move would help the health system expand its brand in an emerging market and reflects […]
People living with chronic health conditions were the first ones to jump on the design bandwagon. In 2009, Amy Tenderich of Diabetes Mine started an annual design contest for insulin pumps. She wanted one that looked more like an iPod than a clunky, ugly medical device. Tenderich went to the best source of ideas for […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
With the drive to value from volume, medical device companies need to start focusing on how to effectively market to patients, their newest customers. Human Design Medical, the company that just launched the smallest, lightest CPAP machine on the market, has done extremely smart marketing for its smart product. When reading about it, I could […]
A medical device company hoping to move sleep apnea testing out of expensive and uncomfortable labs and into the realm of primary care has gotten a boost from at least 20 investors. Watermark Medical Inc., which recently merged with sleep diagnostics provider SleepMed, has raised $32.2 million since March, according to a SEC filing. An […]